SQUAWK/NEWS
Account
Theme
Account
Menu
Live News FX FLASH H impact

Altimmune Announces Third Quarter 2026 Financial Results and Business Update

Global PERFORMA Phase 3 trial in MASH progressing as plannedPositive RECLAIM Phase 2 data in AUD highlighted in a late-breaking oral presentationat AASLD The Liver Meeting® 2026End-of-Phase 2 meeting with FDA for AUD program scheduled for December 2026$480 million in cash, cash equivalents and inve…

ALT
SquawkNews Desk

Related stories

Paysafe Stock Plunges Post Q3 Report — CEO Says Market Headwinds Exceeded Expectations Paysafe (PSFE) shares were on track to hit all-time lows on Thursday, falling approximately 30% in premarket trading after the payments company reported weaker-than-expected third L impact | FX | Nov 12, 2026, 02:13 PM UTC Convera Says Fed Rate-Rise Expectations Should Support Dollar Convera’s market insights team says stronger-than-expected U.S. jobs and inflation data have raised expectations for further Fed rate increases, likely keeping the dollar elevated. M impact | FX | Nov 12, 2026, 01:09 PM UTC Russian gold and forex reserves rise to $724.3 billion The Russian central bank reported reserves of $724.3 billion in the latest week, versus $721.6 billion in the previous week. M impact | FX | Nov 12, 2026, 01:00 PM UTC ING Sees Euro at Risk of Falling Below $1.10 ING's Francesco Pesole says the euro could fall below $1.10 in coming days after reaching an 18-month low of $1.1065 overnight, according to LSEG. A decisive break would probably r M impact | FX | Nov 12, 2026, 09:42 AM UTC Dollar Holds Near 19-Month High as Rate Divergence Stays in Focus M impact | FX | Nov 12, 2026, 09:33 AM UTC US Dollar Climbs on Fed Rate Hike Expectations, Currencies Direct Says The US dollar climbed as expectations for a Federal Reserve rate hike increased, according to Currencies Direct. M impact | FX | Nov 12, 2026, 08:57 AM UTC